Bausch & Lomb Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Bausch & Lomb Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7047
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:43
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Bausch & Lomb Inc (Bausch & Lomb), a subsidiary of Valeant Pharmaceuticals International Inc, is a vision-care company with focus on the protection, enhancement and restoration of eyesight. It offers over-the-counter supplements, eye care products, contact lenses, ophthalmic pharmaceuticals, lens care products, ophthalmic surgical devices and instruments. The company develops, manufactures and markets eye health products for the treatment of a wide range of eye conditions such as glaucoma, conjunctivitis, eye allergies, dry eye and retinal diseases. It has operations across the Americas, Europe, the Middle East, Africa and Asia-Pacific. Bausch & Lomb is headquartered in Bridgewater, New Jersey, the US.

Bausch & Lomb Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Bausch & Lomb Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Bausch & Lomb Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Bausch & Lomb Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Bausch & Lomb Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Bausch & Lomb Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Bausch & Lomb Inc, Medical Equipment, Deal Details 11
Partnerships 11
Bausch & Lomb Enters Into Licensing Agreement With Cirle 11
Unilens Vision Sciences Amends Licensing Agreement With Bausch & Lomb 12
Bausch & Lomb Enters Into Distribution Agreement With PhysIOL For Hydrophilic Acrylic Intraocular Lenses 13
Leica Microsystems Enters Into Distribution Agreement With Bausch & Lomb 14
Bausch & Lomb Enters Into Agreement With Cirle For Medical Technologies 15
Bausch & Lomb Enters Into Licensing Agreement With Paragon BioTeck For Phenylephrine 16
Equity Offering 17
Bausch & Lomb Withdraws IPO 17
Acquisition 19
Bausch & Lomb Acquires Doctor’s Allergy Formula 19
Valeant Pharma Completes Acquisition Of Bausch & Lomb For US$ 8.7 Billion 20
Bausch & Lomb Completes Acquisition Of Remaining Stake In Technolas Perfect Vision From 20/10 Perfect Vision For US$631 Million 22
Abbott, Johnson & Johnson And Sanofi Mull Individual Acquisition Of Bausch & Lomb 24
Bausch & Lomb Inc – Key Competitors 26
Bausch & Lomb Inc – Key Employees 27
Bausch & Lomb Inc – Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Recent Developments 29
Strategy And Business Planning 29
Jul 24, 2018: Bausch + Lomb relocates company archive to new space in Rochester, NY Optics Center Facility, showcasing 165 years of science and innovation 29
Corporate Communications 30
Aug 20, 2018: Joseph Gordon Named U.S. President of Bausch + Lomb 30
Mar 30, 2017: Bausch + Lomb Announces U.S. Management Team Leadership 31
Government and Public Interest 33
Apr 19, 2018: Bausch + Lomb Reports More Than Two Million Used Contact Lens Materials Recycled Through ONE by ONE Program 33
Product News 34
Apr 27, 2018: Bausch + Lomb Will Present Scientific And Clinical Research During The Association For Research In Vision And Ophthalmology Meeting 34
Jun 20, 2017: Bausch + Lomb Unveils AMD Virtual Experience with State-of-the-Art Technology at Optometry’s Meeting 36
May 10, 2017: Bausch + Lomb Reports Updated Results of the Antibiotic Resistance Monitoring in Ocular MicRoorganisms (ARMOR) Study 37
Jan 26, 2017: Bausch + Lomb Specialty Vision Products Introduces ScleralFil Solution for Scleral Lens Insertion 38
Other Significant Developments 39
Apr 19, 2018: Title Bausch + Lomb Reports More than two Million Used Contact Lens Materials Recycled Through ONE By ONE Program 39
Nov 15, 2017: Bausch + Lomb Helps To Recycle More Than One Million Units Of Contact Lens Materials Within First Year Of Launching The ONE By ONE Recycling Program 40
Jul 17, 2017: Bausch + Lomb Launches Innovative Contact Lens Patient Savings & Rewards Program 41
Apr 17, 2017: Bausch + Lomb ONE by ONE Recycling Program Reports Over 180,000 Units of Contact Lenses and Blister Packs Saved from Landfills Since Program Launch 42
Appendix 43
Methodology 43
About GlobalData 43
Contact Us 43
Disclaimer 43

List of Tables
Bausch & Lomb Inc, Medical Equipment, Key Facts 2
Bausch & Lomb Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Bausch & Lomb Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Bausch & Lomb Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Bausch & Lomb Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Bausch & Lomb Inc, Deals By Market, 2012 to YTD 2018 9
Bausch & Lomb Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Bausch & Lomb Enters Into Licensing Agreement With Cirle 11
Unilens Vision Sciences Amends Licensing Agreement With Bausch & Lomb 12
Bausch & Lomb Enters Into Distribution Agreement With PhysIOL For Hydrophilic Acrylic Intraocular Lenses 13
Leica Microsystems Enters Into Distribution Agreement With Bausch & Lomb 14
Bausch & Lomb Enters Into Agreement With Cirle For Medical Technologies 15
Bausch & Lomb Enters Into Licensing Agreement With Paragon BioTeck For Phenylephrine 16
Bausch & Lomb Withdraws IPO 17
Bausch & Lomb Acquires Doctor’s Allergy Formula 19
Valeant Pharma Completes Acquisition Of Bausch & Lomb For US$ 8.7 Billion 20
Bausch & Lomb Completes Acquisition Of Remaining Stake In Technolas Perfect Vision From 20/10 Perfect Vision For US$631 Million 22
Abbott, Johnson & Johnson And Sanofi Mull Individual Acquisition Of Bausch & Lomb 24
Bausch & Lomb Inc, Key Competitors 26
Bausch & Lomb Inc, Key Employees 27
Bausch & Lomb Inc, Other Locations 28
Bausch & Lomb Inc, Subsidiaries 28

List of Figures
Bausch & Lomb Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Bausch & Lomb Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Bausch & Lomb Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Bausch & Lomb Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Bausch & Lomb Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Bausch & Lomb Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Bausch & Lomb Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Bausch & Lomb Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[Bausch & Lomb Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • CryoPort Inc (CYRX):製薬・医療:M&Aディール及び事業提携情報
    Summary Cryoport, Inc. (Cryoport) is a provider of cold chain logistics solutions for temperature-sensitive biological materials to the life science industries. It offers liquid nitrogen dry vapor shippers with advanced logistics management platform called Cryoportal, which provides credentials rela …
  • Britannia Pharmaceuticals Ltd:企業の戦略的SWOT分析
    Britannia Pharmaceuticals Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • UMN Pharma Inc (4585):企業の財務・戦略的SWOT分析
    Summary UMN Pharma Inc (UMN Pharma) is a biopharmaceutical company that manufactures therapeutic for muscular dystrophy, diabetes and influenza. The company’s products include UMN-0501, UMN-0502, UMN-2003, UMN-0901 and UMN-2002, among others. Its UMN-0502 is a seasonal influenza vaccine. UMN Pharma’ …
  • Trinity Industries, Inc.:企業の戦略・SWOT・財務情報
    Trinity Industries, Inc. - Strategy, SWOT and Corporate Finance Report Summary Trinity Industries, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Vascular Solutions Inc-医療機器分野:企業M&A・提携分析
    Summary Vascular Solutions Inc (Vascular Solutions), a subsidiary of Teleflex Inc, is a medical device company that develops and markets clinical solutions for coronary and peripheral vascular procedures. The company’s portfolio spans various types of catheters used for simultaneous pressure measure …
  • ConocoPhillips (COP):電力:M&Aディール及び事業提携情報
    Summary ConocoPhillips is an independent upstream oil and gas company. The company explore for, produce, transport and market crude oil, bitumen, natural gas, liquefied natural gas (LNG) and natural gas liquids across the world. It has assets across North America, Europe, Asia and Australia. Its ass …
  • EnCana Corporation (ECA):石油・ガス:M&Aディール及び事業提携情報
    Summary EnCana Corp (EnCana) is an oil and gas producer. The company explores, develops, produces and markets natural gas, oil and natural gas liquids (NGLs). Its major resource plays include Montney, Duvernay, Wheatland Oil play, Deep Panuke, Horn River and other emerging plays in Canada. In the US …
  • Active Biotech AB (ACTI)-製薬・医療分野:企業M&A・提携分析
    Summary Active Biotech AB (Active Biotech) is a biotechnology company that undertakes the development and commercialization of pharmaceuticals in the field of inflammatory/neurodegenerative diseases and cancer. The company has five projects in clinical development of which three have been licensed o …
  • Enerplus Corp (ERF):企業の財務・戦略的SWOT分析
    Summary Enerplus Corp (Enerplus), formerly Enerplus Resources Fund is an oil and gas company that offers exploration and development services. The company provides exploration and development of natural resource properties for the production of crude oil, light and heavy oil, natural gas, and shallo …
  • Ulster Bank Ireland DAC:企業の戦略的SWOT分析
    Ulster Bank Ireland DAC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • R1 RCM Inc (RCM):企業の財務・戦略的SWOT分析
    R1 RCM Inc (RCM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • DTE Energy Co (DTE):石油・ガス:M&Aディール及び事業提携情報
    Summary DTE Energy Company (DTE Energy) is a diversified energy company that develops and manages energy-related businesses and services. It has presence in the electricity value chain from generation, procurement, to transmission, distribution, and sales. The company procures, stores, and transport …
  • Hill-Rom Holdings, Inc.:戦略・SWOT・企業財務分析
    Hill-Rom Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Hill-Rom Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Press Association:企業の戦略・SWOT・財務情報
    Press Association - Strategy, SWOT and Corporate Finance Report Summary Press Association - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Polyplus-Transfection SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Polyplus-Transfection SA (Polyplus) is a biotechnology company that develops and markets solutions for in vivo and in vitro delivery of nucleic acids in research, bioproduction and therapeutics. The company develops RNA interference such as STICKY SIRNA and SIRNAPLUS for in vivo research. It …
  • Acuity Brands Inc (AYI)-エネルギー分野:企業M&A・提携分析
    Summary Acuity Brands, Inc. (Acuity Brands) provides lighting and building management solutions and services. The company offers lighting solutions including devices such as luminaires, lighting controls, lighting components, power supplies, prismatic skylights, and integrated lighting systems. It a …
  • Coca-Cola Amatil Limited:企業の戦略・SWOT・財務情報
    Coca-Cola Amatil Limited - Strategy, SWOT and Corporate Finance Report Summary Coca-Cola Amatil Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • bioMerieux SA.:企業の戦略・SWOT・財務分析
    bioMerieux SA. - Strategy, SWOT and Corporate Finance Report Summary bioMerieux SA. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Bonanza Creek Energy Inc (BCEI):石油・ガス:M&Aディール及び事業提携情報
    Summary Bonanza Creek Energy Inc (Bonanza Creek) is an oil and gas company that acquires, explores, develops and produces onshore oil and liquid-rich natural gas assets. The company employs hydraulic fracturing for oil and natural gas exploration, and measurement while drilling technology or borehol …
  • Grifols SA (GRF)-医療機器分野:企業M&A・提携分析
    Summary Grifols SA (Grifols) focuses at improving the health and well-being of people around the world. It carries out the research, development, manufacturing and marketing of plasma-derived therapies, hospital pharmacy products and diagnostic technology for clinical use. The company specializes in …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆